On December 16, 2021, the Federal Joint Committee (G-BA) announced the start of the procedure concerning a co-funded study in accordance with §137e of the Social Code Book V (SGB V) for a low-intensity pulsed ultrasound for the treatment of pseudarthroses.
The manufacturer submitted the final (updated) application for the abovementioned co-funded study on September 15, 2021.
Co-funded studies in Germany are regulated in §137e of the SGB V. The framework applies to diagnostic or therapeutic methods that show a potential medical benefit, but the available evidence is not sufficient to decide on inclusion as a benefit within the statutory health insurance. Specific criteria define which methods are eligible for co-funded studies. Manufacturers have the possibility to request a paid consultation by the G-BA to get guidance in the application process for a co-funded study.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.